1. Home
  2. ALKS vs BXSL Comparison

ALKS vs BXSL Comparison

Compare ALKS & BXSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alkermes plc

ALKS

Alkermes plc

HOLD

Current Price

$34.94

Market Cap

5.7B

Sector

Health Care

ML Signal

HOLD

Logo Blackstone Secured Lending Fund of Beneficial Interest

BXSL

Blackstone Secured Lending Fund of Beneficial Interest

HOLD

Current Price

$25.22

Market Cap

6.1B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALKS
BXSL
Founded
1987
2018
Country
Ireland
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
5.7B
6.1B
IPO Year
1991
N/A

Fundamental Metrics

Financial Performance
Metric
ALKS
BXSL
Price
$34.94
$25.22
Analyst Decision
Strong Buy
Buy
Analyst Count
13
8
Target Price
$42.85
$29.13
AVG Volume (30 Days)
2.1M
2.3M
Earning Date
02-13-2026
02-25-2026
Dividend Yield
N/A
12.00%
EPS Growth
2.44
N/A
EPS
2.02
2.66
Revenue
$1,521,338,000.00
$1,413,784,000.00
Revenue This Year
N/A
$9.05
Revenue Next Year
$23.22
N/A
P/E Ratio
$17.21
$9.66
Revenue Growth
1.08
10.58
52 Week Low
$25.17
$24.17
52 Week High
$36.45
$34.64

Technical Indicators

Market Signals
Indicator
ALKS
BXSL
Relative Strength Index (RSI) 65.45 43.33
Support Level $33.35 $24.17
Resistance Level $35.34 $25.77
Average True Range (ATR) 1.08 0.61
MACD -0.02 0.00
Stochastic Oscillator 87.37 39.89

Price Performance

Historical Comparison
ALKS
BXSL

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

About BXSL Blackstone Secured Lending Fund of Beneficial Interest

Blackstone Secured Lending Fund is a non-diversified, closed-end management investment company. The investment objectives of the company are to generate current income and, to a lesser extent, long-term capital appreciation. The company seeks to achieve its investment objectives by investing in originated loans and other securities, including syndicated loans of private U.S. companies, typically in the form of first lien senior secured and unitranche loans, unsecured and subordinated loans, and other securities.

Share on Social Networks: